Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$12.62 USD
+0.36 (2.89%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $12.73 +0.11 (0.87%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NTLA 12.62 +0.36(2.89%)
Will NTLA be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for NTLA based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for NTLA
AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
NTLA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates
Can NTLA's In Vivo Pipeline Aid Long-Term Growth Amid Competition?
Take the Zacks Approach to Beat the Market: UnitedHealth, Ovid, Micron in Focus
Other News for NTLA
Cathie Wood Cuts Stake in Palantir Stock (PLTR) Ahead of Q3, Loads Up on Bullish (BLSH) and Intellia (NTLA)
Is NTLA preparing to trend lower? Lower Bollinger Band Walk shows up after rising 2.89%
DoorDash, Microsoft, Intellia, Upwork, Qorvo: Trending by Analysts
SA analyst upgrades/downgrades: AMZN, NVDA, CMG, NTLA
Gene editing therapy companies rise on word of streamlined FDA approval process